MUC1 and scleroderma: Surfactant Protein D (SP-D) and Krebs von den Lungen-6 (KL-6) are glycoproteins secreted by type II pneumocytes that can be used as markers of disease progression and also to signify the extent of lung involvement in scleroderma (39).